403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
NHS overcharged by millions
(MENAFN) The Competition and Markets Authority has discovered that Concordia, the drug company has overcharged the NHS by millions for a major thyroid treatment.
According to the CMA, in 2016, the NHS paid 34m pound on its drug, liothyronine, up from nearly 600,000 in 2006.
NHS has paid for each pack rose about 4.46 pound in 2007, to 258.19 by July 2017, almost a 6,000% increase.
The price increase was in the times after the drug was de-branded in 2007, and the CMA said the price increased regardless of "broadly stable" production costs.
According to the CMA, in 2016, the NHS paid 34m pound on its drug, liothyronine, up from nearly 600,000 in 2006.
NHS has paid for each pack rose about 4.46 pound in 2007, to 258.19 by July 2017, almost a 6,000% increase.
The price increase was in the times after the drug was de-branded in 2007, and the CMA said the price increased regardless of "broadly stable" production costs.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment